Latest Articles

Subject

Clinical/Scientific Note
Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis
Esther S. Frisch, Darius Häusler, Martin S. Weber

April 18, 2023
Review
Therapies in Stiff-Person SyndromeAdvances and Future Prospects Based on Disease Pathophysiology
Marinos C. Dalakas

April 14, 2023
Research Article
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion
Sophie Huby, Philippe Gelisse, Jean-Jacques Tudesq, et al.

April 14, 2023
Research Article
High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
Robin C.M. Thomma, Christiaan Fokke, Christa Walgaard, et al.

April 14, 2023
Research Article
Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab
Steffen Pfeuffer, Leoni Rolfes, Jens Ingwersen, et al.

April 11, 2023
Research Article
Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
Josefine Sell, Vahid Rahmati, Marin Kempfer, et al.

April 07, 2023
Research Article
Lesional Antibody Synthesis and Complement Deposition Associate With De Novo Antineuronal Antibody Synthesis After Spinal Cord Injury
Jan M. Schwab, Carmen Haider, Marcel A. Kopp, et al.

April 05, 2023
Diagnostic & Treatment Challenges
Relapsing Encephalomyelitis After COVID-19 Infection and VaccinationFrom the National MS Society Case Conference Proceedings
Shuvro Roy, Paula Barreras, Carlos A. Pardo, et al.

April 04, 2023
Clinical/Scientific Note
Prolonged Corticosteroids Without Maintenance Immunotherapy for Treatment of Anti-LGI1 EncephalitisAnalysis of Outcomes and Relapse Rate
Samir Alkabie, Adrian Budhram

April 04, 2023
Correction & Replacement
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis
March 27, 2023

Pages